MENU
CNTX
AS OF
Jan 15, 04:59 PM (EDT)
Price
$1.51
Change
-$0.06 (-3.82%)
Capitalization
144.25M
69 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
CNTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Context Therapeutics (CNTX) Earnings Date & Reports

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors... Show more

A.I. Advisor
published Earnings

CNTX is expected to report earnings to rise 2.50% to -10 cents per share on March 25

Context Therapeutics CNTX Stock Earnings Reports
Q4'25
Est.
$-0.10
Q3'25
Missed
by $0.01
Q2'25
Missed
by $0.03
Q1'25
Beat
by $0.07
Q4'24
Beat
by $0.03
The last earnings report on November 06 showed earnings per share of -10 cents, missing the estimate of -9 cents. With 510.26K shares outstanding, the current market capitalization sits at 144.25M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
CNTX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CNTX showed earnings on November 06, 2025. You can read more about the earnings report here.
View AI-Driven Trading for CNTX
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2001 Market Street
Phone
+1 267 225-7416
Employees
5
Web
https://www.contexttherapeutics.com